MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202518066199 A) filed by Neuroderm, Ltd., Rehovot, Israel, on July 11, for 'liquid compositions comprising a levodopa amino acid conjugate and uses thereof.'
Inventor(s) include Kenji Morokuma; Daisuke Iijima; Masataka Okuno; Akira Nakao; Liora Braiman-Wiksman; Elana Gazal; Ronit Shaltiel-Karyo; Alex Mainfeld; Eduardo Zawoznik; and Shmuel Ben-Hamo.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "Disclosed herein are liquid pharmaceutical formulations comprising levodopa amino acid conjugates that may further comprise a decarboxylase inhibitor, such as carbidopa, an antioxidant, a solvent, or any other pharmaceutically acceptable excipient. Further disclosed are methods of treating generative conditions and/or conditions characterized by reduced levels of dopamine in the brain, such as Parkinson's disease, comprising administering the disclosed liquid pharmaceutical formulations. Disclosed also are LDAA conjugate compounds."
The patent application was internationally filed on Sept. 03, 2020, under International application No.PCT/IL2020/050960.
Disclaimer: Curated by HT Syndication.
